The purpose of this study is to learn more about the body’s immune response to genital herpes infections. To be eligible for the study you must be 18 years of age or older, test positive for HSV-2 antibodies by a blood test, and experience genital herpes outbreaks.
Category: Research Studies
Immune Response Following Monkeypox (MPOX) Infection
This is a study of the immune response to monkeypox infection. Participants must be 18 years of age or older.
Monkeypox (MPOX) Vaccination & Immune Response
The purpose of this study is to learn more about the body’s immune response to monkeypox vaccination. The study may last for up to 3 months and involve 5-6 study visits.
Immunogenicity of Fractional Dose of the HPV Vaccines
The purpose of this research study is to determine if a fractional dose of the HPV vaccine produces a detectable immune response. The study will last for one year and involve 4 visits.
COVAIL COVID-19 Vaccine Trial
The purpose of this clinical trial is to test the safety and effectiveness of additional COVID-19 booster doses in people who have already received a primary COVID-19 vaccination series and booster dose. Participants will have completed a primary COVID-19 vaccination series (2 doses of Pfizer, 2 doses of Moderna, or 1 dose of Johnson & Johnson) and received a booster at least 16 weeks prior to joining the study.
“Mix ‘n Match” Booster COVID-19 Vaccine Trial
This is a Phase 1/2 COVID-19 vaccine booster trial. The purpose of this clinical trial is to test the safety and effectiveness of a booster dose of the Novavax sub-unit protein vaccine in people who have received an EUA vaccine series.
Gritstone COVID-19 Vaccine Trial
The purpose of this trial is to test investigational chimpanzee Adenovirus and self-amplifying mRNA prime-boost prophylactic vaccines against SARS-CoV-2 in healthy adults.
Immunity Study
We have identified a genetic marker in people of African descent that could increase the risk of acquiring HIV. The purpose of this study is to find out whether factors in the genital area of the body can change how your body fights HIV.
VIVA Trial
The VIVA Clinical Trial (Vaccine to Interrupt Progression of Vulvar and Anal Neoplasia) will test whether the Human Papillomavirus (HPV) vaccine can improve the health of people who have been previously diagnosed with pre-cancerous lesions.
More: Past Studies
VRC studies over the decades